GenScript ProBio

Feb 18, 2021

GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology

Dec 07, 2020

Through Strategic Collaboration with GenScript ProBio, Initium Therapeutics Plans to Utilize GenScript ProBio's Berkeley Lights Beacon Platform to Expand Their Antibody Drug Pipeline

Sep 24, 2020

GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program

Sep 17, 2020

Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.

Jul 21, 2020

GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

Apr 07, 2020

GenScript ProBio and Eutilex Enter into Exclusive Strategic Collaboration on Plasmid and Virus Process Development and Manufacturing for CAR-T Programs

Mar 27, 2020

GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial